ASN Renal Week day 3: My talk

I spoke on the openning day in one of the big rooms. This was my first talk at a national meeting (though I did do an oral presentation to a small room for the American Society of Hypertension but the room held only about 50 people. This felt like a thousand.

To see the room before it filled you will need to go to the old blogspot site (and see how small video from an iPhone was in 2010).

Here is the talk.

3 Replies to “ASN Renal Week day 3: My talk”

  1. Excellent presentation. Awesome.

    Just a few small comments, mostly to NSF part:

    1. There are cases of NSF in patients without any Gd exposure unlike you quoted: Wahba IM, Simpson EL, White K. Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature. Am J Transplant 2007; 7(10):2425-32. and Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris ST et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007; 245(1):168-75

    2. Gd clearance is worse in PD patients with PD. Still, there are no NSF cases in PD patients!!

    ENjoy, Thanks for presentation. Excellent


  2. Spiderman,

    Since my talk was not on NSF but rather on avoiding harm in ARF patients I don't think that cases of NSF not triggered by Gd are relavent, though it is interesting. Additionally the PD data is intriguing but since my point was that dialysis did not seem to be protective I don't believe this data is relavent to my talk.

    Thanks for the comments.

  3. SOrry if I hurt ur feelings in anyways. You talk was amazing for sure.

    I was working on NSF paper and am so confused about the data myself that I thought you would be interested in the data. As always, great job.

    Friendly Neighborhood Spider-Man!

Comments are closed.